Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
The antiviral drug remdesivir is being tested in several ongoing trials of COVID-19 patients. Gilead stated that one of these studies, run by the US National Institutes of Health, shows the drug works.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Coronavirus research: flaws in trials for remdesivir, chloroquine - Business Insider'We have no reliable data' on potential coronavirus treatments, one researcher said. Here's how that could change over the next few weeks.
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »
Coronavirus: EU rewrote coronavirus report after pressure by China - Business InsiderReferences to a Chinese campaign of 'global disinformation' about the coronavirus were removed before publication. China wins again! Shame on EU !
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »
Coronavirus antibody treatments: Eli Lilly, Regeneron, GSK, Amgen - Business Insider4 top drugmakers are studying the body's own efforts to fight off viruses as they race to find a COVID-19 treatment that could be ready by the fall Yaaaaay Yeah seriously, I can't stop itching all over!!!!
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »